Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment

INTRODUCTION AND OBJECTIVE: COVID-19 is an ongoing, global public health crisis for which safe and effective treatments need to be identified. The benefit-risk balance for the use of lopinavir-ritonavir in COVID-19 needs to be monitored on an ongoing basis, therefore a systematic benefit-risk assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Osborne, Vicki, Davies, Miranda, Lane, Samantha, Evans, Alison, Denyer, Jacqueline, Dhanda, Sandeep, Roy, Debabrata, Shakir, Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309686/
https://www.ncbi.nlm.nih.gov/pubmed/32578156
http://dx.doi.org/10.1007/s40264-020-00966-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309686/
https://www.ncbi.nlm.nih.gov/pubmed/32578156
http://dx.doi.org/10.1007/s40264-020-00966-9

Ejemplares similares